REDWOOD CITY, Calif., May 8, 2023 /PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today reported financial results for the first...
News Ticker
- [ June 8, 2023 ] BehaVR Appoints Former Pear Therapeutics, TytoCare and AVIA Executives to Senior Leadership Team News
- [ June 8, 2023 ] Carta Healthcare Secures $25 Million in Series B Funding with Additional Investments from Memorial Hermann Health System and UnityPoint Health News
- [ June 8, 2023 ] Activate Welcomes a Record 46 New Activate Fellows Whose Innovations Can Decarbonize Industries and Build a Cleaner, Safer Society News
- [ June 8, 2023 ] apree health Launches a New Comprehensive Navigation and Clinical Advocacy Solution News
- [ June 8, 2023 ] Human Resources Director – Henlius Biotech – Milpitas, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
